Scibase AB
SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin c… Read more
Scibase AB - Asset Resilience Ratio
Scibase AB (SCIB) has an Asset Resilience Ratio of 45.86% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2024)
This chart shows how Scibase AB's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Scibase AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr24.76 Million | 45.86% |
| Short-term Investments | Skr0.00 | 0% |
| Total Liquid Assets | Skr24.76 Million | 45.86% |
Asset Resilience Insights
- Very High Liquidity: Scibase AB maintains exceptional liquid asset reserves at 45.86% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Scibase AB Industry Peers by Asset Resilience Ratio
Compare Scibase AB's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
|
Osang Healthcare Co.,Ltd
KQ:036220 |
Medical Devices | 9.34% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
Annual Asset Resilience Ratio for Scibase AB (2012–2024)
The table below shows the annual Asset Resilience Ratio data for Scibase AB.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 18.22% | Skr11.24 Million | Skr61.73 Million | -34.82pp |
| 2023-12-31 | 53.04% | Skr34.12 Million | Skr64.33 Million | +15.26pp |
| 2022-12-31 | 37.77% | Skr18.83 Million | Skr49.85 Million | -39.00pp |
| 2021-12-31 | 76.77% | Skr65.61 Million | Skr85.46 Million | +6.86pp |
| 2020-12-31 | 69.92% | Skr41.43 Million | Skr59.25 Million | +12.61pp |
| 2019-12-31 | 57.31% | Skr26.46 Million | Skr46.16 Million | -25.92pp |
| 2018-12-31 | 83.23% | Skr67.51 Million | Skr81.11 Million | -2.77pp |
| 2017-12-31 | 86.01% | Skr110.02 Million | Skr127.91 Million | +2.81pp |
| 2016-12-31 | 83.20% | Skr84.95 Million | Skr102.11 Million | +78.75pp |
| 2012-12-31 | 4.45% | Skr1.06 Million | Skr23.87 Million | -- |